1. Home
  2. ENTA vs GTN Comparison

ENTA vs GTN Comparison

Compare ENTA & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.63

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

GTN

Gray Television Inc.

HOLD

Current Price

$5.51

Market Cap

446.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
GTN
Founded
1995
1897
Country
United States
United States
Employees
N/A
9582
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
446.1M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
GTN
Price
$14.63
$5.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$20.40
$8.50
AVG Volume (30 Days)
114.8K
1.1M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
6.09%
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
$13.89
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$11.72
Revenue Growth
16.48
N/A
52 Week Low
$4.73
$3.13
52 Week High
$17.15
$6.31

Technical Indicators

Market Signals
Indicator
ENTA
GTN
Relative Strength Index (RSI) 66.38 67.59
Support Level $13.39 $4.25
Resistance Level $15.52 $5.55
Average True Range (ATR) 0.82 0.25
MACD 0.25 0.10
Stochastic Oscillator 94.87 99.44

Price Performance

Historical Comparison
ENTA
GTN

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

Share on Social Networks: